Psychedelic Clinical Trials
Find clinical trials studying psilocybin, MDMA, ketamine and other psychedelics. Many trials are actively recruiting participants who haven't found relief from conventional treatments.
Precision Functional Brain Mapping in Psilocybin
Washington University School of Medicine
Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study
Imperial College London
Pilot RECAP Study in Healthy Volunteers
University of Wisconsin, Madison
Discontinuation of Disease Modifying Therapies (DMTs) in Multiple Sclerosis (MS): Extension of the DISCOMS Study
University of Colorado, Denver
Evaluation of Psilocybin in Anorexia Nervosa: Safety and Efficacy
University of California, San Diego
Ketamine Versus Fentanyl for Surgical Abortions
University of Washington
Effect of Postoperative Single Dose of Ketamine on Pain After Mastectomy
NYU Langone Health
A Long-Term Extension Study for Participants With Treatment-resistant Major Depressive Disorder Who Are Continuing Esketamine Nasal Spray Treatment
Janssen-Cilag Ltd.
An Efficacy and Safety of Proprietary Formulations of Oral Ketamine + Aspirin in Treatment of Acute Headache
Antonios Likourezos
A Comparison of Proprietary Formulations of Oral Ketamine + Aspirin and Oral Ketamine Alone for Musculoskeletal Pain
Antonios Likourezos
The Impact of Perioperative Ketamine Infusion on Surgical Recovery
Vanderbilt University Medical Center
Modified Ketogenic Diet and Ketamine for Anorexia Nervosa
Homeostasis Therapeutics, LLC
A Study of Oral Ibogaine in Opioid Withdrawal
atai Therapeutics, Inc.
Study of CT001 in Healthy Volunteers
Cessatech A/S
Ketamine-enhanced Prolonged Exposure Therapy in PTSD
VA Office of Research and Development
A Multi-Site Open-Label Extension Study of MDMA-Assisted Psychotherapy for PTSD
Resilient Pharmaceuticals
Cognitive Behavioral Therapy Following Esketamine for Major Depression and Suicidal Ideation for Relapse Prevention
Yale University
RelieVRx for Total Knee Arthroplasty (TKA) for the Reduction of Acute Postoperative Pain and Opioid Use
AppliedVR Inc.
Long-Term Safety and Effectiveness of MDMA-Assisted Therapy for PTSD
Resilient Pharmaceuticals
Safety and Efficacy of Psilocybin for Body Dysmorphic Disorder
New York State Psychiatric Institute
Effects of Dimethyl Fumarate on Cognitive Performance and Brain Abnormalities in Multiple Sclerosis.
IRCCS Centro Neurolesi Bonino Pulejo
Circulating Oxytocin Changes in Response to the Oxytocin System Stimulator MDMA in Patients With Diabetes Insipidus and Healthy Controls
University Hospital, Basel, Switzerland
SPL026 (DMT Fumarate) in Healthy Subjects and MDD Patients
Small Pharma Ltd
Prospective Multicentre Study of the Use of Ketamine in the Treatment of Refractory Chronic Pain in the French CLCC
Centre Leon Berard
Exploring Sedation Types During Cataract Surgery
Vance Thompson Vision
Pharmacogenetics Associated With IV Ketamine
Brain and Cognition Discovery Foundation
Ketamine for Pain Control After Severe Traumatic Injury
Medical College of Wisconsin
Inpatient Single Dose Interventions for Alcohol Use Disorder
Denver Health and Hospital Authority
Music as an Intervention to Improve Hemodynamic Tolerability of Ketamine in Depression
Douglas Mental Health University Institute
Phase 1 Evaluation of (2R,6R)-Hydroxynorketamine
National Institute of Mental Health (NIMH)
Analgesic Efficacy of Orally Administered VTS-K for Pain Management
Antonios Likourezos
The Effect of Psilocybin on MDD Symptom Severity and Synaptic Density
Section for Affective Disorders; Northern Stockholm Psychiatry
Effects of MDMA Co-administration on the Response to LSD in Healthy Subjects
University Hospital, Basel, Switzerland
Cardiac Index and General Anesthesia Without Opioid.
Centre Hospitalier de Montauban
A Study of SLS-002 (Intranasal Racemic Ketamine) in Adults With Major Depressive Disorder at Imminent Risk of Suicide
Seelos Therapeutics, Inc.
Ketamine for the Treatment of Opioid Use Disorder and Depression
Medical University of South Carolina
A Study in Healthy Men to Test Whether BI 409306, BI 425809 or Lamotrigine Can Reverse the Memory Problems Caused by Ketamine
Boehringer Ingelheim
Relative Bioavailability Study of MELT-100, IV Midazolam, and IV Ketamine
Melt Pharmaceuticals
Neurodynamics of Prosocial Emotional Processing Following Serotonergic Stimulation With N,N-Dimethyltryptamine (DMT) and Harmine in Healthy Subjects
Psychiatric University Hospital, Zurich
Characteristics, Adherence, and Persistence Among Multiple Sclerosis Patients Treated With Disease-Modifying Therapies
Novartis
The Ketamine for Acute Postoperative Analgesia (KAPA) Trial
University Health Network, Toronto
Ketamine to Prevent PPD After Cesarean
Washington University School of Medicine
Pro-inflammatory Role of Blood Platelets in Critically Ill Patients With Septic Shock.
University Hospital, Bordeaux
A Study of Esketamine Nasal Spray, Administered as Monotherapy, in Adult Participants With Treatment-resistant Depression
Janssen Research & Development, LLC
Preliminary Efficacy and Safety of Ibogaine in the Treatment of Methadone Detoxification
International Center for Ethnobotanical Education, Research, and Service
Ketamine for Older Adults Pilot
Washington University School of Medicine
Effect of Ketanserin After LSD Administration
University Hospital, Basel, Switzerland
Ketamine Treatment Effects on Synaptic Plasticity in Depression
New York State Psychiatric Institute
Browse by Condition
View all conditions →How to Join a Clinical Trial
Clinical trials are research studies that test new treatments. Participating can give you access to cutting-edge therapies while contributing to medical science. Each trial has specific eligibility criteria based on the research goals.
1. Review
Read the trial details, eligibility criteria, and what participation involves.
2. Contact
Reach out to the study team using the contact information provided.
3. Screen
Complete the screening process to determine if you're eligible.